Revolutionary Japanese treatment for lymphangioma;Japansk metod revolutionerar behandlingen av lymfangiom

Lakartidningen

Volumn , Issue 18, 1998, Pages 2074-2077

  Claesson, Gösta ^a,c   Gordon, Lena ^b   Kuylenstierna, Richard ^b  

^a Biträdande Överläkare ^*  (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c S:t Gorans Sjukhus   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PICIBANIL;

ARTICLE; CLINICAL TRIAL; CYSTIC LYMPHANGIOMA; ECHOGRAPHY; FEMALE; HUMAN; INFANT; INJECTION; JAPAN; MALE; METHODOLOGY; PRESCHOOL CHILD; RADIOGRAPHY; SWEDEN;

ANTINEOPLASTIC AGENTS; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INJECTIONS; JAPAN; LYMPHANGIOMA, CYSTIC; MALE; PICIBANIL; SWEDEN;

EID: 0032576934     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Ninh TN, Ninh TX. Cystic hygroma in children: A report of 126 cases. J Pediatr Surg 1974; 9: 191-5.
2. Emery PJ, Bailey CM, Evans JNG. Cystic hygroma of the head and neck: A review of 37 cases. J Laryngol Otol 1984; 98: 613-9.
3. Yura J, Hashimoto T, Tsuruga N, Shibata K. Bleornycin treatment for cystic hygroma in children. Arch Japan Chir 1977; 46: 607-14.
4. Svendsen P, Gunterberg B. Städa bland hemangiomen! Läkartidningen, 1997; 94: 137-9.
5. Brock ME, Smith RJH, Parey SE, Mobley DL. Lymfangioma. An otolaryngologic perspective. Int J Pediatr Otorhinolaryngol 1987; 14: 133-40.
6. Tovi M, Herbreteau D, Enjolras O, Merland JJ. Perkutan skleroterapi - cnkel, snabb och repetitiv. Läkartidningen 1998; 95: 643-7.
7. Ogita S, Tsuto T, Tokiwa K, Takashi T. Intracystic injection of OK-432: a new sclerosing therapy for cystic hygroma in children. Br J Surg 1987; 74: 690-1.
8. Ogita S, Tsuto T, Deguchi E, Tokiwa K, Nagashima M, Iwai N. OK-432-therapy for unresectable lymphangiomas in children. J Pediatr Surg 1991; 26: 263-70.
9. Ogita S, Tsuto T, Nakamura K, Deguchi E, Iwai N. OK-432 therapy in 64 patients with lymfangioma. J Pediatr Surg 1994; 29: 784-5.
10. Ishida N, Hoshino T. A streptococcal preparation as a potent biological response modifier; OK-432 for cystic hygroma in children. Geka 1987; 49: 421-3.
11. Chabner B, Myers C, Coleman N, Johns D. The clinical pharmacology of antineoplastic agents (second of two parts). N Engl J Med 1975; 292: 1159-68.
12. Bera F, Jonville-Bera AP, Bandaly F, Bochereau G, Autret E. Cardiorespiratory arrest after injection of Trombovar (sodium tetradecyl sulfate). Therapie 1993; 48: 519-20.
13. Ishida N, Saito M. How have we elucidated the mechanism of action of OK-432? - Effector cells and cytokine induction. Biotherapy 1990; 4: 155-65.
14. Tsuchihashi Y, Ogita S. Histopathological study of the effect of OK-432 on lymphangioma of an infant. J Kyoto Pref Univ Med 1993; 102: 1055-60.
15. Ullberg M, Tewodros W, Kronvall G. Receptors for human plasminogen on the biological response modifier OK-432. Journal of Biological Response Modifiers 1990; 9: 592-6.
16. Ogita S, Tsuto T, Nakamura K, Deguchi E, Tokiwa K, Iwai N. OK-432 therapy for lymphangioma in children: Why and how does it work? J Pediatr Surg 1996; 31: 477-80.